Gregory Gan

Assistant Professor

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Gregory Gan is an Assistant Professor at the University of Kansas Medical Center, United States. His research focuses on radiation therapy, cancer biology, and the impact of social-ecological factors on treatment outcomes, particularly in head and neck cancers. Recent publications include investigations into p16 negative head and neck cancer and patient-specific modeling of radiation-induced lymphopenia.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2020

Collaborators (3)

Christine Bestvina

Assistant Professor

University of Chicago Medicine

UNITED STATES

View details

Andres Bur

Associate Professor

University of Kansas Medical Center

UNITED STATES

View details

Jun Zhang

Associate Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Gan

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasis

Patient‐specific modeling of radiation‐induced lymphopenia for head and neck cancer

Multi‐collimator proton minibeam radiotherapy with joint dose and PVDR optimization

DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.

Loss of MK2 Enhances Radiation-Mediated Apoptosis in Bladder Cancer

Development and characterization of the first proton minibeam system for single‐gantry proton facility

Assessing the Risk of Adjuvant Radiotherapy Initiation Delays With Social Support Surveys

Association of Social-Ecological Factors With Delay in Time to Initiation of Postoperative Radiation Therapy

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline

Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy

Predicting salvage laryngectomy in patients treated with primary nonsurgical therapy for laryngeal squamous cell carcinoma using machine learning.

Collaborators (3)

Christine Bestvina

Andres Bur

Jun Zhang

Make your next move.